Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Hyoscine Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Hyoscine Butylbromide
  • 1.3.3 Hyoscine Hydrobromide
• 1.4 Market Segment by Application
  • 1.4.1 Global Hyoscine Market Share by Application (2019-2025)
  • 1.4.2 Oral
  • 1.4.3 Injections
  • 1.4.4 Patches
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Hyoscine Market Size
  • 2.1.1 Global Hyoscine Revenue 2014-2025
  • 2.1.2 Global Hyoscine Sales 2014-2025
• 2.2 Hyoscine Growth Rate by Regions
  • 2.2.1 Global Hyoscine Sales by Regions 2014-2019
  • 2.2.2 Global Hyoscine Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Hyoscine Sales by Manufacturers
  • 3.1.1 Hyoscine Sales by Manufacturers 2014-2019
  • 3.1.2 Hyoscine Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Hyoscine Revenue by Manufacturers (2014-2019)
  • 3.2.2 Hyoscine Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Hyoscine Market Concentration Ratio (CR5 and HHI)
• 3.3 Hyoscine Price by Manufacturers
• 3.4 Key Manufacturers Hyoscine Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Hyoscine Market
• 3.6 Key Manufacturers Hyoscine Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Hyoscine Butylbromide Sales and Revenue (2014-2019)
  • 4.1.2 Hyoscine Hydrobromide Sales and Revenue (2014-2019)
• 4.2 Global Hyoscine Sales Market Share by Type
• 4.3 Global Hyoscine Revenue Market Share by Type
• 4.4 Hyoscine Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Hyoscine Sales by Application

6 United States

• 6.1 United States Hyoscine Breakdown Data by Company
• 6.2 United States Hyoscine Breakdown Data by Type
• 6.3 United States Hyoscine Breakdown Data by Application

7 European Union

• 7.1 European Union Hyoscine Breakdown Data by Company
• 7.2 European Union Hyoscine Breakdown Data by Type
• 7.3 European Union Hyoscine Breakdown Data by Application

8 China

• 8.1 China Hyoscine Breakdown Data by Company
• 8.2 China Hyoscine Breakdown Data by Type
• 8.3 China Hyoscine Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Hyoscine Breakdown Data by Company
• 9.2 Rest of World Hyoscine Breakdown Data by Type
• 9.3 Rest of World Hyoscine Breakdown Data by Application
• 9.4 Rest of World Hyoscine Breakdown Data by Countries
  • 9.4.1 Rest of World Hyoscine Sales by Countries
  • 9.4.2 Rest of World Hyoscine Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Alchem International Ltd.
  • 10.1.1 Alchem International Ltd. Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Hyoscine
  • 10.1.4 Hyoscine Product Introduction
  • 10.1.5 Alchem International Ltd. Recent Development
• 10.2 Alkaloids Corporation
  • 10.2.1 Alkaloids Corporation Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Hyoscine
  • 10.2.4 Hyoscine Product Introduction
  • 10.2.5 Alkaloids Corporation Recent Development
• 10.3 Baxter International Inc.
  • 10.3.1 Baxter International Inc. Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Hyoscine
  • 10.3.4 Hyoscine Product Introduction
  • 10.3.5 Baxter International Inc. Recent Development
• 10.4 Caleb Pharmaceuticals, Inc.
  • 10.4.1 Caleb Pharmaceuticals, Inc. Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Hyoscine
  • 10.4.4 Hyoscine Product Introduction
  • 10.4.5 Caleb Pharmaceuticals, Inc. Recent Development
• 10.5 Centroflora Cms S. R.L.
  • 10.5.1 Centroflora Cms S. R.L. Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Hyoscine
  • 10.5.4 Hyoscine Product Introduction
  • 10.5.5 Centroflora Cms S. R.L. Recent Development
• 10.6 GlaxoSmithKline Plc
  • 10.6.1 GlaxoSmithKline Plc Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Hyoscine
  • 10.6.4 Hyoscine Product Introduction
  • 10.6.5 GlaxoSmithKline Plc Recent Development
• 10.7 Guangzhou Hanfang Pharmaceutical Co., Ltd.
  • 10.7.1 Guangzhou Hanfang Pharmaceutical Co., Ltd. Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Hyoscine
  • 10.7.4 Hyoscine Product Introduction
  • 10.7.5 Guangzhou Hanfang Pharmaceutical Co., Ltd. Recent Development
• 10.8 Myungmoon Pharma Co., Ltd.
  • 10.8.1 Myungmoon Pharma Co., Ltd. Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Hyoscine
  • 10.8.4 Hyoscine Product Introduction
  • 10.8.5 Myungmoon Pharma Co., Ltd. Recent Development
• 10.9 Novartis International AG
  • 10.9.1 Novartis International AG Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Hyoscine
  • 10.9.4 Hyoscine Product Introduction
  • 10.9.5 Novartis International AG Recent Development
• 10.10 Perrigo Company Plc
  • 10.10.1 Perrigo Company Plc Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Hyoscine
  • 10.10.4 Hyoscine Product Introduction
  • 10.10.5 Perrigo Company Plc Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Hyoscine Sales Channels
  • 11.2.2 Hyoscine Distributors
• 11.3 Hyoscine Customers

12 Market Forecast

• 12.1 Global Hyoscine Sales and Revenue Forecast 2019-2025
• 12.2 Global Hyoscine Sales Forecast by Type
• 12.3 Global Hyoscine Sales Forecast by Application
• 12.4 Hyoscine Forecast by Regions
  • 12.4.1 Global Hyoscine Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Hyoscine Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Hyoscine, also referred as scopolamine, is utilized as a medicine to treat motion sickness, gastrointestinal spasms, vomiting, and postoperative nausea. In addition, it is utilized sometimes before surgery to decrease saliva. Hyoscine belongs to antimuscarinic family and works by blocking some acetylcholine effects within the nervous system.
Rise in consumer awareness towards hyoscine as an effective medicine against motion sickness is the primary factor that drive the growth of the hyoscine market.
In 2019, the market size of Hyoscine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hyoscine.

This report studies the global market size of Hyoscine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Hyoscine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Alchem International Ltd.
Alkaloids Corporation
Baxter International Inc.
Caleb Pharmaceuticals, Inc.
Centroflora Cms S. R.L.
GlaxoSmithKline Plc
Guangzhou Hanfang Pharmaceutical Co., Ltd.
Myungmoon Pharma Co., Ltd.
Novartis International AG
Perrigo Company Plc

Market Segment by Product Type
Hyoscine Butylbromide
Hyoscine Hydrobromide

Market Segment by Application
Oral
Injections
Patches

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Hyoscine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Hyoscine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Hyoscine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025